Reported Standalone quarterly numbers for Astec Lifesciences are:
Net Sales at Rs 153.75 crore in March 2024 up 21.09% from Rs. 126.97 crore in March 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.99 crore in March 2024 up 80.21% from Rs. 5.00 crore in March 2023.
EBITDA stands at Rs. 14.74 crore in March 2024 up 85.18% from Rs. 7.96 crore in March 2023.
Astec Life shares closed at 1,235.00 on May 02, 2024 (BSE) and has given -1.33% returns over the last 6 months and -8.57% over the last 12 months.
Story continues below Advertisement
| Astec Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 153.75 | 50.79 | 126.97 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 153.75 | 50.79 | 126.97 | | EXPENDITURE | | Consumption of Raw Materials | 82.50 | 43.17 | 76.49 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 22.82 | -7.85 | 9.76 | | Power & Fuel | -- | -- | -- | | Employees Cost | 14.69 | 14.43 | 12.86 | | Depreciation | 9.02 | 8.72 | 7.77 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 21.03 | 19.37 | 22.47 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 3.69 | -27.05 | -2.37 | | Other Income | 2.03 | 0.90 | 2.57 | | P/L Before Int., Excpt. Items & Tax | 5.72 | -26.15 | 0.19 | | Interest | 6.68 | 6.10 | 6.41 | | P/L Before Exceptional Items & Tax | -0.96 | -32.25 | -6.21 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.96 | -32.25 | -6.21 | | Tax | 0.03 | -7.90 | -1.22 | | P/L After Tax from Ordinary Activities | -0.99 | -24.35 | -5.00 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.99 | -24.35 | -5.00 | | Equity Share Capital | 19.61 | 19.61 | 19.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.50 | -12.42 | -2.55 | | Diluted EPS | -0.50 | -12.42 | -2.55 | | EPS After Extra Ordinary | | Basic EPS | -0.50 | -12.42 | -2.55 | | Diluted EPS | -0.50 | -12.42 | -2.55 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
